Single-Pulse Transcranial Magnetic Stimulation (sTMS) Technology: eNeura's SAVI Dual Device and Its Role in the Migraine Market.

IF 0.3 4区医学 Q4 ENGINEERING, BIOMEDICAL

IEEE Pulse Pub Date : 2025-03-01 DOI:10.1109/MPULS.2025.3554830

Eric Bohlen

引用次数: 0

Abstract

Migraine, a debilitating neurological disorder affecting over 1 billion people worldwide, has long challenged medical science due to its complex pathophysiology and variable treatment responses. Single-pulse transcranial magnetic stimulation (sTMS), a noninvasive central neuromodulation technique, has emerged as a promising therapeutic option. Developed by eNeura Inc., the SAVI Dual device leverages sTMS to provide both acute and preventive migraine relief by targeting hyperactive neural networks in the brain. This article explores the technical underpinnings of SAVI Dual, traces the history of clinical studies that shaped sTMS for neuromodulation, and evaluates its position within the evolving migraine market.

查看原文本刊更多论文

单脉冲经颅磁刺激（sTMS）技术：eNeura的SAVI双装置及其在偏头痛市场中的作用。

偏头痛是一种影响全球超过10亿人的衰弱性神经系统疾病，由于其复杂的病理生理和多变的治疗反应，长期以来一直挑战着医学科学。单脉冲经颅磁刺激（sTMS）是一种无创中枢神经调节技术，已成为一种有前景的治疗选择。SAVI Dual设备由eNeura公司开发，利用sTMS通过靶向大脑中过度活跃的神经网络来提供急性和预防性偏头痛缓解。本文探讨了SAVI Dual的技术基础，追溯了形成sTMS用于神经调节的临床研究历史，并评估了其在不断发展的偏头痛市场中的地位。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

IEEE Pulse ENGINEERING, BIOMEDICAL-

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： IEEE Pulse covers both general and technical articles on current technologies and methods used in biomedical and clinical engineering; societal implications of medical technologies; current news items; book reviews; patent descriptions; and correspondence. Special interest departments, students, law, clinical engineering, ethics, new products, society news, historical features and government.